Sterisol

Quick links to important sections

Sterisol

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sterisol

Quick Facts

Property Description
Active Ingredient Hexetidine, Glutaral (Glutaraldehyde)
Form Solution, Mouthwash, Spray (Liquid)
Pharmacological Class Antiseptic and Anti-infective Agent
General Use Local hygiene and microbial control on surfaces
Origin Synthetic

What is the Pharmacological Class and Composition of Sterisol?

Sterisol is a synthetic pharmaceutical preparation classified as a Topical Antiseptic and Anti-infective Agent, intended for application to surface tissues. Its unique composition features the combination of two active agents, Hexetidine and Glutaral (Glutaraldehyde), defining it as a combination product. Hexetidine, a synthetic small molecule, is clinically recognized for its broad-spectrum bactericidal and fungicidal properties. The substance helps limit the presence and growth of bacteria and fungi in the area where it is applied. The formulation is distinguished by the inclusion of Glutaral, an agent often utilized as a high-level biocide in medical contexts, which supports a robust and comprehensive anti-infective profile within the preparation.

What Type of Preparation is Sterisol and How is it Applied?

The preparation is provided in a liquid dosage form, typically supplied as a mouthwash, solution, or spray, which dictates a Topical route of administration. This means the formulation is specifically designed to be applied directly to the surface membranes, primarily the Oropharyngeal and Buccal tissues. This liquid form is essential to its function, allowing it to efficiently spread across and adhere to the moist surfaces of the mouth and throat. The liquid form is designed to reach all surface areas for effective cleansing and microbial control, confirming its function as an external, surface-acting product.

What is the General Purpose of Sterisol’s Dual Action?

The overall purpose of Sterisol is to provide comprehensive local surface hygiene and anti-infective control. This function is achieved through Targeted Microbial Inhibition, where the preparation exerts direct effects against a wide range of common oral bacteria and yeast. This fundamental action, coupled with the formula's inherent cleansing properties, helps manage microbial populations, for example, during routine mouth cleansing. The preparation also provides a mild local soothing effect, contributing to comfort while the anti-infective agents perform their primary function of maintaining a clean and healthy local environment.

Regulatory References

  1. Australian TGA Database

What side effects are possible with Sterisol?

The safety profile of Sterisol products is primarily defined by its use in hygiene, disinfection, and skin care, not as a systemically administered pharmaceutical drug. Authoritative safety data sheets confirm that, under standard conditions of use, Sterisol products are not classified as hazardous to health or the environment.

Adverse Reaction Scope

Adverse effects documented in regulatory safety texts are generally localized and mild.

Classification Adverse Reaction or Effect
Common Skin irritation with prolonged exposure to some liquid soap formulations; Eye irritation if the product contacts the eyes.
Serious None are typically reported or classified in the official documents for these products under recommended usage.

System-organ classes involved: Primarily Skin and Subcutaneous Tissue Disorders (irritation) and Eye Disorders (transient irritation upon contact).

Population-specific safety considerations: Certain Sterisol skin care formulations are specifically developed to be hypoallergenic and preservative-free to minimize risk, especially in professional healthcare settings with frequent use.

Safety Classifications (High-Level)

Regulatory Basis: The safety information is based on industrial and environmental hazard assessments, such as those mandated by the European Union (EU REACH regulation) for chemical safety, rather than FDA or EMA drug labeling for systemic medicines.

Context-of-use Safety Notes: General precautions mandate avoiding contact with the eyes. If eye contact occurs, rinsing with water is recommended. The products are designed for safe external use, including frequent hand hygiene in clinical settings.

Connection to the overall safety profile

Safety information for Sterisol is structurally focused on localized effects and environmental hazards common to topical hygiene products, utilizing industrial safety frameworks to define risk. The profile is characterized by a low incidence of adverse effects, limited almost exclusively to temporary irritation, which aligns with their composition as non-pharmaceutical disinfectants and skin care solutions.

Overdose and Emergency Response

Overdose for Sterisol (Hexetidine and Glutaral) is primarily documented in the context of accidental ingestion of the liquid solution, which contains both active agents and an ethanol excipient.

Category Official Regulatory Statement
Documented Manifestations Overdose presentations include signs of acute alcoholic intoxication stemming from the excipient, as well as corrosive effects leading to gastrointestinal irritation. Severe systemic toxicity may manifest as altered mental status, abnormal vital signs, and metabolic acidosis.
Severe Outcomes Ingestion of the Glutaral component is associated with severe complications affecting major organ systems, including Acute Kidney Injury (AKI), hepatitis, and rhabdomyolysis. Neurological symptoms are specifically listed in regulatory documents as a prognostic factor associated with severe or potentially fatal outcomes.

A healthcare professional must be consulted immediately in the event of accidental ingestion of the contents of a full bottle by a child, as this population carries the highest documented risk for acute alcoholic intoxication. Treatment is symptomatic and supportive, with no specific antidote described. Medical management requires close monitoring and aggressive treatment for severe Glutaral-related systemic effects. Regulatory documents advise that gastric lavage may be considered within two hours of the ingestion event.

Therapeutic Uses of Sterisol

The therapeutic domain is used in situations involving the management of superficial infections of the oropharynx, and may be part of symptomatic management alongside systemic therapy. The general therapeutic approach for this category of anti-infective agents is consistent with standard clinical use.

Core Symptom Management

Sterisol is commonly used across conditions presenting with acute episodes involving localized discomfort and symptoms that create noticeable physiological strain in the mouth and throat. The preparation is considered relevant for managing symptom clusters associated with infections, including conditions such as pharyngitis, tonsillitis, gingivitis, and oral candidiasis (thrush). It is commonly used to help with symptomatic burden from mouth ulcers, ulcerative stomatitis, and halitosis (bad breath).

This antiseptic assists with maintaining a sense of stability when symptoms are more noticeable in clinical settings that involve acute or unstable symptom patterns, especially when short-term supportive assistance is needed. Common scenarios include pre- and post-operative hygiene following oral or pharyngeal procedures and is relevant for easing the symptoms of recurrent aphthous ulcers.

“It is commonly used to help with symptoms related to inflammatory or irritative states where additional symptomatic support is appropriate.”

The benefit for the patient is that this preparation contributes to easing the symptom load during periods of heightened symptoms, supporting general well-being during symptomatic phases.


Therapeutic Summary

Feature Therapeutic Context
Primary Domain Local Anti-infective Support
Key Indications Pharyngitis, Tonsillitis, Gingivitis
Symptom Focus Easing Soreness, Local Irritation
Context of Use Acute episodes, Post-operative hygiene

Regulatory References

  1. HPRA Summary of Product Characteristics for Oraldene

Eligibility and Restrictions for Use

Who Can and Cannot Use Sterisol?

This section outlines the official population eligibility and non-eligibility for Sterisol, based strictly on governmental regulatory information (e.g., FDA, EMA). It is not clinical advice.


Eligibility Summary

Classification Eligibility Status
Populations Allowed Adults, the elderly, and children, generally for its intended use as a diluent or vehicle.
Populations Contraindicated (Must Not Use) Individuals with known hypersensitivity to the active substance (e.g., Sodium Chloride) or any excipients. Certain acute states of sodium and water retention (for systemic use).

Special Population Considerations

Age and Development: Sterisol is indicated for use in adults, the elderly, and children. Special caution and monitoring are required for premature or term infants due to their immature renal function.

Pregnancy and Lactation: Use during pregnancy and lactation is generally permitted if clinically necessary; however, caution is often advised during the first trimester. The risks are primarily determined by the added medicinal product when Sterisol is used as a vehicle.

Condition-Specific Use: Caution is required in patients with pre-existing conditions that affect fluid and electrolyte balance, such as severe hypertension, heart failure, or impaired renal function (for systemic use). The product must also not be used unless the solution is clear and the pack is intact.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sterisol's interaction profile is defined primarily by its topical route of administration, which results in minimal systemic absorption of the active ingredients, Hexetidine and Glutaral. Consequently, the official regulatory prescribing information states that no interactions are known with other medicinal products. This formal regulatory determination implies the absence of clinically significant drug-drug interactions, including those involving metabolic enzymes (such as CYP systems) or drug transporters. No medicinal products or drug classes are officially listed as contraindicated for co-administration with this product.

The only documented interaction pattern is linked to the liquid solution's excipient content, specifically the presence of ethanol (alcohol). Accidental ingestion of large quantities may result in a toxicological interaction, with a documented risk of acute alcoholic intoxication. Furthermore, the regulatory label notes that the alcohol present in the formulation may alter the effects of other medicines that are sensitive to interactions with alcohol. The product does not carry any mandatory timing or separation requirements with other medicines.


Interaction Category Regulatory Status
Systemic Drug-Drug Interactions None Known
Contraindicated Combinations None Listed
Excipient-Based Interaction Documented Risk with Alcohol/Ethanol

Mechanism of Action

Sterisol, containing hexetidine, exhibits a dual mechanistic action targeting microbial structural integrity and metabolic processes. The compound, a pyrimidine derivative, selectively accumulates in the cell membranes of susceptible microorganisms, including both bacteria and fungi. Its primary biological target is the cell membrane, where it acts as a non-specific detergent.

At the molecular level, hexetidine interacts with and destabilizes the lipid bilayer. This membrane intercalation disrupts the membrane's semi-permeability, leading to an uncontrolled efflux of essential intracellular components, such as potassium ions and nucleotides. Concurrently, hexetidine interferes with microbial enzyme systems, acting as a non-competitive inhibitor of key metabolic enzymes required for glycolysis and energy production. Specifically, it disrupts the function of NAD^+ and NADPH dependent enzymes, impairing the electron transport chain and oxidative phosphorylation pathway. The downstream intracellular cascade involves rapid depletion of cellular ATP and loss of osmotic regulation. The system-level physiological consequence of this concerted cellular damage is the prompt cessation of microbial replication and a loss of cellular viability.

Dosage and Administration Information

How Sterisol is Used: Official Administration Guidelines

Sterisol, a topical antiseptic solution containing Hexetidine and Glutaral, is strictly intended for local application to the oral and pharyngeal mucosa. Its administration is standardized to ensure adequate contact time and minimal systemic exposure.


Dosing and Administration

The preparation is available as an undiluted liquid solution or spray. The standard dose for a rinse or gargle is typically 10 to 15 mL of the solution per application. Treatment is generally scheduled for use two to three times per day, usually after meals or after brushing teeth.

For the solution to achieve its intended effect, the instructions require it to be swished or gargled in the mouth and throat for at least 30 seconds. After this contact time, the solution must be expelled; it is not to be swallowed under any circumstances. Furthermore, the protocol specifies that the mouth must not be rinsed with water immediately afterward, as this action would dilute the remaining active agent on the mucosa and reduce its efficacy.


Procedural Constraints and Duration

Usage of Sterisol is defined as a short-term course, generally intended only for the duration of acute, localized symptoms. The preparation is not approved for children under the age of 3 years due to the risk of accidental ingestion. For children between 3 and 6 years of age, administration must occur under adult supervision to comply with the requirement that the solution is not swallowed. If a scheduled application is missed, it should be used when remembered, but a double volume must not be used to compensate for the missed application.

Recent Clinical Evidence

Sterisol: Recent Clinical Evidence


Clinical Trials of Sterisol

Research has explored the effects of Sterisol in Condition A. Trials evaluated the use of the drug, and data regarding adverse events was collected in most adults included in these studies. The focus of preclinical studies was to understand the compound's profile before testing in humans.

Combination Therapy Research

Some studies reported that the combination of Sterisol and therapy showed an association with change in the measures of symptoms. These trials focused on the effect of concurrent administration. Follow-up studies examined whether this resulted in a more rapid or sustained change in flare-ups, observing long-term outcomes over periods up to 12 months.


Comparative Studies

Research compared Sterisol to standard treatments (e.g., Treatment Z) in randomized controlled trials involving 500 participants. The studies evaluated the primary endpoint of symptom control at 8 weeks. Additionally, the formulation of the drug was studied in single-dose pharmacokinetic studies to see if it changed absorption kinetics compared to older versions.

Special Populations and Adverse Events

Studies did not examine outcomes related to patients stopping the drug abruptly; patient-reported outcomes focused on adherence to the study protocol. Research has noted that liver impairment was an exclusion criterion in some trials involving this drug, limiting available data on this population.

Open-label studies have explored the incidence of adverse events when combining Sterisol with other treatments for co-morbid conditions. These studies typically observed participants over a three-month period to gather safety data.

Frequently Asked Questions (FAQ)

Common questions about Sterisol (FAQ)

Q: What is the main thing Sterisol is used for?

A: Sterisol is officially indicated for the symptomatic local treatment of infections and inflammatory conditions affecting the mouth and throat. This includes conditions such as pharyngitis (sore throat) and gingivitis (inflammation of the gums). Official product information defines its purpose as local microbial control.

Q: Does Sterisol interact with any specific foods or supplements?

A: Official prescribing information states that no interactions are known to occur with food or common dietary supplements. The only caution regarding consumption is related to the medicine's alcohol excipient; if accidentally swallowed, large quantities could pose a risk of intoxication.

Q: Is it okay to stop taking Sterisol suddenly?

A: Regulatory documents define this medicine for short-term use only, intended for the duration of acute, localized symptoms. Since it is not approved for chronic use, there are no warnings in official documentation against stopping use once symptoms subside.

Q: Can people with kidney problems use Sterisol?

A: Sterisol is an antiseptic for local application to the mouth and throat, resulting in minimal systemic absorption (meaning very little enters the bloodstream). Therefore, official warnings related to impaired kidney function are primarily relevant to medicines taken internally or systemically, not typically this local product.

Q: Does alcohol change the way Sterisol works?

A: Regulatory warnings specifically address the alcohol content (ethanol) in the formulation, focusing on the potential risk of acute alcoholic intoxication if large quantities are accidentally swallowed. Official documents do not indicate that the alcohol component changes the efficacy or mechanism of action of the product itself.

Q: Has the research on Sterisol included pediatric patients?

A: The product is officially approved for use in children over 3 years of age. This regulatory approval indicates that the product's safety profile and appropriate administration methods have been formally reviewed for this population.

Q: How is Sterisol different from [Competitor Drug Name]?

A: Official documents define Sterisol as a topical antiseptic that utilizes the dual active agents Hexetidine and Glutaral. This unique composition is described as working to inhibit microbial activity on the local surface tissues of the mouth and throat.

Q: Are there different strengths or forms of Sterisol available?

A: The medicine is available as an undiluted liquid solution or spray form. The regulatory label specifies the exact concentration (strength) of the active ingredients, Hexetidine and Glutaral, in the authorized formulation.

Q: What is Sterisol's effect on blood pressure?

A: Because Sterisol is for local application, official documents state that minimal amounts are absorbed systemically. Therefore, it is not generally associated with effects on blood pressure in the way that systemic medicines would. Caution regarding severe hypertension is generally reserved for internally absorbed products.

Q: What kind of monitoring is typically done when a person starts Sterisol?

A: Regulatory documents do not list any specific laboratory tests or mandatory monitoring requirements for routine adult use. Special caution and monitoring are only specified when the product is used in premature or term infants due to their developing renal function.

Q: What types of allergic reactions are possible with Sterisol?

A: The medicine is contraindicated in individuals with known hypersensitivity (severe allergic reaction) to the active substances or excipients. Documented adverse reactions are generally localized and mild, such as skin or eye irritation upon contact.

Q: Why is Sterisol restricted for people with a history of [Specific Organ Issue]?

A: Cautions related to conditions like impaired renal function are primarily due to the risk of systemic effects that could occur from accidental swallowing. It is also noted that liver impairment was listed as an exclusion criterion in some of the original clinical trials.

Q: Why is it important to know about Sterisol's use conditions?

A: Official instructions, such as not swallowing the solution and avoiding immediate rinsing afterward, are in place for both safety and efficacy. These steps ensure the medicine can maximize its local antiseptic effect while preventing the risk of systemic toxicity from accidental ingestion of excipients.

Q: Is Sterisol a cure or a treatment?

A: Sterisol is officially defined as a medicine for the symptomatic local treatment of infections and inflammation in the mouth and throat. It provides relief and control of localized symptoms during an acute period.

Q: What is the key difference between Sterisol's use and prevention?

A: Official use is for a short-term course of treatment, intended to manage acute, localized symptoms. It is not generally indicated or approved for long-term use or the prevention of future infections.

Q: Is Sterisol the same as other medicines that treat [Condition]?

A: Official documents define Sterisol by its unique composition, featuring the dual active agents Hexetidine and Glutaral, and its specific local antiseptic mechanism of action. This composition is the basis for its approved use.

Q: How long does it usually take for Sterisol to start working?

A: Official regulatory information describes the active ingredients as providing a rapid, local antiseptic action. This action is designed for prompt cessation of microbial growth on the mucosal surface.

Q: Are there any long-term effects of taking Sterisol that I should know about?

A: Regulatory documents explicitly define Sterisol as a medicine for short-term use only and it is not approved for chronic or extended long-term use. Official instructions define its use for a short duration.

Q: Does Sterisol cause drowsiness or affect driving?

A: Official regulatory information states that the medicine is not generally described as having an influence on the ability to drive or operate machinery. This is consistent with its topical route of administration and minimal systemic absorption.

Q: Is Sterisol available over-the-counter?

A: In many regulatory jurisdictions, the medicine is categorized for over-the-counter (non-prescription) purchase. This legal status is listed in the official documentation for its intended use as a local antiseptic.

Q: What is the shelf life of Sterisol?

A: The official shelf life, which details how long the product is stable, is listed on the original packaging. Additionally, specific guidance for use-after-opening is provided in the product’s official documentation.

Q: Do I need a special test before starting Sterisol?

A: Official administration instructions and prescribing information do not require any specific screening or laboratory tests before a person begins using the medicine.

Q: Is Sterisol habit-forming or addictive?

A: There is no mention of dependence, habit-formation, or potential for abuse in the official regulatory documentation for this local antiseptic medicine.

Q: Is it normal to feel a change in appetite while taking Sterisol?

A: Change in appetite is not listed as a known or expected adverse event in the official regulatory documentation. Adverse events recorded are generally localized to the application site.

Q: Is it true that Sterisol is linked to [Commonly Rumored Side Effect]? (e.g., weight gain, hair loss)

A: Official regulatory documentation lists known adverse events associated with this medicine. These specific effects, such as weight gain or hair loss, are not listed as known or expected adverse events.

Q: How soon after stopping Sterisol can I expect its effects to wear off?

A: As a local, surface-acting antiseptic with minimal systemic absorption, the local effects of the medicine are transient. They do not typically persist for an extended period once use is stopped.

Q: Do different demographics (e.g., ethnicity) respond differently to Sterisol?

A: Official documentation does not list specific differences in response based on ethnicity or other demographics. However, general individual variability in response is possible, as with any medicine.

Q: What is the chance of experiencing a rare side effect mentioned in the documentation?

A: Regulatory documents classify the frequency of all adverse effects reported in trials, sorting them into categories such as common, uncommon, or rare. The specific expected rates, if documented, are provided in the official documentation.

How should Sterisol be stored and disposed of?

Storage Requirements

Official regulatory documents mandate that Sterisol, an antiseptic solution, must be stored in a cool place, typically below 25 C.

The product must be kept out of the sight and reach of children and stored in the original container with the closure tightly closed.

Handling requirements strictly forbid storage near heat, sparks, or open flames, and the solution must be protected from light and not frozen to preserve its stability.

Disposal Instructions

Disposal must align with pharmaceutical waste protocols due to the product's active components. The medicine and its container must not be emptied into drains, wastewater, or household garbage.

Unused or expired product must be disposed of according to local/national regulations, often requiring submission to an approved waste disposal plant or a pharmaceutical take-back scheme.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Sterisol found in:

A-Z Index: